$1.6M of planned sales filed in 30 days · 0.3% of the units outstanding
Filed 10/01
Stocks
All tracked funds
All 5% stake reports on ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Health care sectorNasdaq
What to see in ARS Pharmaceuticals now
Company
- Exchange
- Nasdaq
- Sector
- Health care
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Fiscal year end
- 12/31
- Next earnings
- 11/10, estimated
- BlackRock holds 5.3% · +0.3pp on the report beforeFiled 07/27
- 206 13F filers hold it · +3 against the quarter before · shares held −3.6%Holdings of 06/30
Funds
13F filers: 206 · +3 since the quarter before · 06/30 holdings
Famous funds that held ARS Pharmaceuticals in their latest 13F report.
| Fund | Value | Since the quarter before |
|---|---|---|
| Third PointARS Pharmaceuticals SPRY · 06/30 holdings | $8M | No change |
| Mirae Asset Global ETFS HoldingsARS Pharmaceuticals SPRY · 06/30 holdings | $290.5K | No quarter before |
| Mirae Asset Global InvestmentsARS Pharmaceuticals SPRY · 06/30 holdings | $35.6K | Trimmed −13.9% |
5% stakes
| Holder | ||
|---|---|---|
| BlackRock07/27 | 5.3%5,218,264 sh | +0.3pp |
| Millennium Management07/14 | 2.5%2,520,937 sh | −3.5pp |
| Rubric Capital Management05/15 | 8.06%8,000,000 sh | +1.8pp |
| BlackRock04/27 | 4.98%4,946,412 sh | −0.1pp |
| Millennium Management03/24 | 5.4%5,391,440 sh | First report |
| Rubric Capital Management02/13 | 6.27%6,200,000 sh | First report |
| BlackRock01/21 | 5.1%5,013,000 sh | First report |
| Ra Capital Management25/10/01 | 11.1%10,940,977 sh | No earlier report |
| James E. Flynn25/08/01 | 7.75%7,610,217 sh | −1.0pp |
| James E. Flynn25/07/22 | 8.79%8,633,537 sh | −1.1pp |
| James E. Flynn25/07/02 | 9.9%9,724,508 sh | −0.8pp |
| James E. Flynn25/03/24 | 10.72%10,514,657 sh | No earlier report |